Urine Steroid Hormone Profile Analysis in Cytochrome P450 Oxidoreductase Deficiency: Implication for the Backdoor Pathway to Dihydrotestosterone
The DOI matches its Crossref record; 20 of the 21 references it cites were found in a registry or an index.
Abstract
Context: Although the “backdoor” pathway to dihydrotestosterone has been postulated in the fetal-to-early-infantile period of patients with cytochrome P450 oxidoreductase deficiency (PORD), clinical data in support of this pathway remain limited. Objective: The objective of this study was to obtain clinical evidence for the presence of the backdoor pathway in PORD. Setting: This was a collaboration study between laboratories and hospitals. Subjects: Twenty-two Japanese patients with molecularly confirmed PORD and 1763 control subjects participated in this study. Intervention: Urine steroid profile analysis was performed by gas chromatography/mass spectrometry. In five patients and 776 control subjects, urine samples were obtained before 12 months of age. Main Outcome Measure: The main outcome measure was identification of a urine steroid(s) indicating the backdoor pathway. Results: In the PORD patients, pregnanediol, pregnanetriolone, and pregnanetriol were obviously elevated, and the urine steroid ratios reflecting CYP17A1 and CYP21A2 activities were decreased throughout the examined ages. Furthermore, etiocholanolone and 11-hydroxyandrosterone, which should originate almost exclusively from androstenedione in the conventional “frontdoor” pathway, were grossly normal or somewhat decreased since early infancy, whereas androsterone, which can be derived not only from androstenedione and dihydrotestosterone in the conventional frontdoor pathway but also from 5α-pregnane-3α,17α-diol-20-one in the backdoor pathway, was increased during early infancy and remained grossly normal thereafter. Thus, the androsterone to etiocholanolone ratio was increased during early infancy and remained grossly normal thereafter. 5α-Pregnane-3α,17α-diol-20-one was elevated throughout the examined ages. Conclusions: The increased androsterone excretion during early infancy, as compared with the etiocholanolone and 11-hydroxyandrosterone excretions in the same period, suggests the presence of the backdoor pathway in PORD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mass spectrometric analyses of urinary steroids in patients with POR deficiency confirm that all the steroidal intermediates in the backdoor pathway are produced in infants, children and adults with severe POR deficiency and pregnant women carrying a POR-deficient fetus (316, 331, 651), and adults with mild POR deficiency (283).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [651]
In the citing paper
“subsequent studies have described increased alternative pathway metabolite excretion in patients with CAH due to POR 125”
From Congenital adrenal hyperplasia (2017) · cites this paper as [125]
In the citing paper
“some mutations of POR that have less effect on aromatase are associated with increased backdoor androgen production [56,57]”
From Alternative (backdoor) androgen production and masculinization in the human fetus (2019) · cites this paper as [57]
In the citing paper
“In humans, the backdoor pathway is relevant in pathological conditions when 17OHPROG accumulates, such as in congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency (PORD) or 21-hydroxylase deficiency (Arlt et al., 2004, Homma et al., 2006, Kamrath et al., 2012, Krone et al., 2012, Miller and Auchus, 2011).”
From Intracrine androgen biosynthesis, metabolism and action revisited (2018) · cites this paper as Homma et al., 2006
Citations
Cites
Mutant P450 oxidoreductase causes disordered steroidogenesis with and without Antley-Bixler syndrome
Flück, C. E., Tajima, T., Pandey, A. V., Arlt, W., Okuhara, K., Verge, C. F., Jabs, E. W., Mendonça, B. B., Fujieda, K., & Miller, W. L. (2004) · Nature Genetics · doi:10.1038/ng1300 · Cited by 509
Self-citationDisorders of sex differentiation
Grumbach, M. M. (1992) · Medical Entomology and Zoology · Cited by 402
Estrogen: Consequences and Implications of Human Mutations in Synthesis and Action1
Grumbach, M. M., & Auchus, R. J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.12.6290 · Cited by 368
The backdoor pathway to dihydrotestosterone
Auchus, R. J. (2004) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2004.09.004 · Cited by 347
Arlt, W., Walker, E. A., Draper, N., Ivison, H. E., Ride, J. P., Hammer, F., Chalder, S. M., Borucka-Mankiewicz, M., Hauffa, B. P., Malunowicz, E. M., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16503-3 · Cited by 345
Huang, N., Pandey, A. V., Agrawal, V., Reardon, W., Lapunzina, P. D., Mowat, D., Jabs, E. W., Vliet, G. V., Sack, J., Flück, C. E., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/429417 · Cited by 336
Estrogen: Consequences and Implications of Human Mutations in Synthesis and Action
Grumbach, M. M. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.12.4677 · Cited by 298
Wilson, J. D., Auchus, R. J., Leihy, M. W., Guryev, O. L., Estabrook, R. W., Osborn, S. M., Shaw, G., & Renfree, M. B. (2003) · Endocrinology · doi:10.1210/en.2002-220721 · Cited by 172
Fukami, M., Horikawa, R., Nagai, T., Tanaka, T., Naiki, Y., Sato, N., Okuyama, T., Nakai, H., Soneda, S., Tachibana, K., et al. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0810 · Cited by 155
Self-citationAdachi, M., Tachibana, K., Asakura, Y., Yamamoto, T., Hanaki, K., & Oka, A. (2004) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.30169 · Cited by 110
Self-citation
Cited by
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Speiser, P. W., Azziz, R., Baskin, L. S., Ghizzoni, L., Hensle, T. W., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Montori, V. M., Oberfield, S. E., et al. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2631 · Cited by 1,468
Congenital adrenal hyperplasia
El-Maouche, D., Arlt, W., & Merke, D. P. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31431-9 · Cited by 669
Congenital Adrenal Hyperplasia—Current Insights in Pathophysiology, Diagnostics, and Management
Claahsen - van der Grinten, H. L., Speiser, P. W., Ahmed, S. F., Arlt, W., Auchus, R. J., Falhammar, H., Flück, C. E., Guasti, L., Huebner, A., Kortmann, B. B. M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab016 · Cited by 556
Disorders of sex development: a new definition and classification
Hughes, I. A. (2008) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2007.11.001 · Cited by 438
Metadata
- Authors
- Homma, K., Hasegawa, T., Nagai, T., Adachi, M., Horikawa, R., Fujiwara, I., Tajima, T., Takeda, R., Fukami, M., & Ogata, T.
- Affiliations
- Departments of Laboratory Medicine (K.H.) Tokyo 160-8582, Japan
- Keio University (JP)
- Dokkyo University (JP)
- Kanagawa Children's Medical Center (JP)
- National Center For Child Health and Development (JP)
- Tohoku University (JP)
- Hokkaido University (JP)
- Shirakawa Kosei General Hospital (JP)
- National Research Institute for Child Health and Development (JP)
- Corresponding author
- Ogata, Tsutomu
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2006-07-01
- Volume
- 91
- Issue
- 7
- Pages
- 2643-2649
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2136516201
- Semantic Scholar
- 3748bebc0bec4df2e1b481c4194d33b62569730a
- Cited by
- 153
- References
- 21
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 2 · 2023: 5 · 2022: 11 · 2021: 7 · 2020: 7 · 2019: 12 · 2018: 9 · 2017: 9 · 2016: 11 · 2015: 8 · 2014: 4 · 2013: 3 · 2012: 7
- FWCI
- 3.51
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Army Research Office
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Keywords
- dihydrotestosterone, androsterone, pregnanediol, pregnanetriol, etiocholanolone, androstenedione, CYP17A1, CYP21A2, congenital adrenal hyperplasia
- MeSH terms
- Adolescent, Adult, Androsterone, Child, Child, Preschool, Etiocholanolone, Female, Humans, Infant, Infant, Newborn, Gas Chromatography-Mass Spectrometry, Mutation, NADPH-Ferrihemoprotein Reductase, Pregnanediones, Gonadal Steroid Hormones, Dihydrotestosterone, Steroid 17-alpha-Hydroxylase, Steroid 21-Hydroxylase, Mutation, Missense
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Urine Steroid Hormone Profile Analysis in Cytochrome P450 Oxidoreductase Deficiency: Implication for the Backdoor Pathway to Dihydrotestosterone. https://app.cochat.ai/papers/10.1210/jc.2005-2460
- The paper
- Homma, K., Hasegawa, T., Nagai, T., Adachi, M., Horikawa, R., Fujiwara, I., Tajima, T., Takeda, R., Fukami, M., & Ogata, T. (2006). Urine Steroid Hormone Profile Analysis in Cytochrome P450 Oxidoreductase Deficiency: Implication for the Backdoor Pathway to Dihydrotestosterone. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2005-2460
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.